Seeking biotech investment, breakthrough innovations, or a strategic gateway to the Asia-Pacific? The answers await in Hong Kong this September.HONG KONG, July 7, 2026 /PRNewswire/ -- The 5th Hong ...
Island Pharmaceutical’s experimental drug will be used to treat patients in Uganda, as the African nation grapples with the ...
Market Index on MSN
Why CSL is rallying like a growth stock again
CSL is up 35.5% since early June, clearing its 50-day moving average for the first time in nearly a year. Is the biotech ...
The parent of bankESB and TruNorth Bank will end its 157-year history as a depositor-owned institution, in part to fund the ...
The infrastructure moment for AI-driven drug discovery continues to accelerate, with billion-dollar investments flowing into ...
Brandon Capital will receive more than $300 million from the sale of Myricx, which is developing cancer-killing “biological ...
Brandon Capital, a life sciences venture capital firm has exited from its investment in Myricx Bio, following its agreement to be acquired by Novartis for US$1.5 billion ($2.2bn).
The payment gives Aligos non-dilutive funding as it advances its pipeline of treatments for liver and viral diseases.
6h
A drug already in human trials could reverse tooth loss by 2030, a condition that affects millions
Japanese biotech drug aims to reverse tooth loss by regrowing teeth. Here's how TRG-035 works, where trials stand and when it ...
United Therapeutics is a Buy: strong core growth, a goal of $1B quarterly revenue by 2027, plus catalysts ralinepag & Tyvaso ...
8hon MSN
You have a dormant set of tooth buds and scientists want to activate them to regrow missing teeth
Activating a set of sleeping buds everyone has in their jaw could put an end to tooth loss in less than 5 years, says new ...
Biotech is having a moment, and the numbers are hard to ignore. The SPDR S&P Biotech ETF (NYSEARCA:XBI) climbed 17.27% over ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results